Infectious Mononucleosis Therapy
New infectious mononucleosis therapy study findings recently were reported by researchers at University of Minnesota, Department of Laboratory Medicine
Published in TB and Outbreaks Week, June 19th, 2007
Data detailed in "A virologic pilot study of valacyclovir in infectious mononucleosis" have been presented. According to a study from the United States, "Infectious mononucleosis decreases the productivity of many college students and Epstein-Barr virus (EBV) infection may result in long-term immune damage. Evaluate the antiviral effect of valacyclovir during EBV-related acute infectious mononucleosis and explore potential clinical benefits. University students who presented during the first 7 days of illness were randomized to receive valacyclovir 3g/day for 14 days or not. The quantity of Epstein-Barr virus (EBV) DNA in oral and whole blood samples was determined by real-time (TaqMan)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bioterrorism
Abiomed Appoints Eric A. Rose, M.D., a Leader in Circulatory Care, to Its Board of Directors - Bioterrorism
Panic Over Infected U.S. Citizen is Just the Tip of the Nightmare: New Strains of Tuberculosis Can Be Used as a Powerful Bioterror Weapon - Bird Flu
Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference - Bird Flu
Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show - Epidemic
GlaxoSmithKline Launches Educational Campaign in Detroit to Address 'Silent Epidemic' of Genital Herpes Among African American Adults - Epidemic
World No Tobacco Day Focuses on Secondhand Smoke - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
